Real Estate - Services
Compare Stocks
5 / 10Stock Comparison
BEKE vs WELL vs VTR vs COMP vs OHI
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Healthcare Facilities
Software - Application
REIT - Healthcare Facilities
BEKE vs WELL vs VTR vs COMP vs OHI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Real Estate - Services | REIT - Healthcare Facilities | REIT - Healthcare Facilities | Software - Application | REIT - Healthcare Facilities |
| Market Cap | $61.48B | $149.25B | $41.15B | $5.32B | $13.74B |
| Revenue (TTM) | $103.52B | $11.63B | $6.13B | $8.31B | $1.24B |
| Net Income (TTM) | $3.48B | $1.43B | $260M | $14M | $632M |
| Gross Margin | 21.9% | 39.1% | -4.3% | 10.8% | 85.5% |
| Operating Margin | 3.2% | 4.4% | 13.4% | -4.2% | 64.3% |
| Forward P/E | 3.3x | 78.4x | 118.0x | 53.5x | 23.4x |
| Total Debt | $22.65B | $21.38B | $13.22B | $454M | $4.26B |
| Cash & Equiv. | $11.44B | $5.03B | $741M | $199M | $27M |
BEKE vs WELL vs VTR vs COMP vs OHI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Apr 21 | May 26 | Return |
|---|---|---|---|
| KE Holdings Inc. (BEKE) | 100 | 35.4 | -64.6% |
| Welltower Inc. (WELL) | 100 | 283.9 | +183.9% |
| Ventas, Inc. (VTR) | 100 | 156.0 | +56.0% |
| Compass, Inc. (COMP) | 100 | 46.0 | -54.0% |
| Omega Healthcare In… (OHI) | 100 | 121.4 | +21.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BEKE vs WELL vs VTR vs COMP vs OHI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BEKE ranks third and is worth considering specifically for value.
- Lower P/E (3.3x vs 53.5x)
WELL is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth 35.8%, EPS growth -11.5%, 3Y rev CAGR 22.7%
- 223.1% 10Y total return vs OHI's 110.0%
- Lower volatility, beta 0.13, Low D/E 49.5%, current ratio 5.34x
- 35.8% FFO/revenue growth vs OHI's 14.0%
VTR is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 1 yrs, beta 0.01, yield 2.1%
- Beta 0.01, yield 2.1%, current ratio 0.96x
- Beta 0.01 vs COMP's 1.79
Among these 5 stocks, COMP doesn't own a clear edge in any measured category.
OHI carries the broadest edge in this set and is the clearest fit for quality and dividends.
- 51.0% margin vs COMP's 0.2%
- 5.4% yield, vs BEKE's 1.9%, (1 stock pays no dividend)
- 6.1% ROA vs COMP's 0.4%, ROIC 6.0% vs -2.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 35.8% FFO/revenue growth vs OHI's 14.0% | |
| Value | Lower P/E (3.3x vs 53.5x) | |
| Quality / Margins | 51.0% margin vs COMP's 0.2% | |
| Stability / Safety | Beta 0.01 vs COMP's 1.79 | |
| Dividends | 5.4% yield, vs BEKE's 1.9%, (1 stock pays no dividend) | |
| Momentum (1Y) | +42.7% vs BEKE's -4.8% | |
| Efficiency (ROA) | 6.1% ROA vs COMP's 0.4%, ROIC 6.0% vs -2.5% |
BEKE vs WELL vs VTR vs COMP vs OHI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
BEKE vs WELL vs VTR vs COMP vs OHI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
OHI leads in 2 of 6 categories
WELL leads 1 • BEKE leads 0 • VTR leads 0 • COMP leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
OHI leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
BEKE is the larger business by revenue, generating $103.5B annually — 83.6x OHI's $1.2B. OHI is the more profitable business, keeping 51.0% of every revenue dollar as net income compared to COMP's 0.2%. On growth, COMP holds the edge at +99.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $103.5B | $11.6B | $6.1B | $8.3B | $1.2B |
| EBITDAEarnings before interest/tax | $4.3B | $2.8B | $2.3B | -$100M | $1.1B |
| Net IncomeAfter-tax profit | $3.5B | $1.4B | $260M | $14M | $632M |
| Free Cash FlowCash after capex | $2.4B | $2.5B | $1.4B | $16M | $912M |
| Gross MarginGross profit ÷ Revenue | +21.9% | +39.1% | -4.3% | +10.8% | +85.5% |
| Operating MarginEBIT ÷ Revenue | +3.2% | +4.4% | +13.4% | -4.2% | +64.3% |
| Net MarginNet income ÷ Revenue | +3.4% | +12.3% | +4.2% | +0.2% | +51.0% |
| FCF MarginFCF ÷ Revenue | +2.3% | +21.9% | +22.4% | +0.2% | +73.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.1% | +40.3% | +22.0% | +99.4% | +16.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -32.7% | +22.5% | 0.0% | +133.3% | +42.4% |
Valuation Metrics
Evenly matched — BEKE and COMP and OHI each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 23.8x trailing earnings, OHI trades at a 85% valuation discount to VTR's 160.3x P/E. On an enterprise value basis, OHI's 16.7x EV/EBITDA is more attractive than BEKE's 89.9x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $61.5B | $149.2B | $41.1B | $5.3B | $13.7B |
| Enterprise ValueMkt cap + debt − cash | $63.1B | $165.6B | $53.6B | $5.6B | $18.0B |
| Trailing P/EPrice ÷ TTM EPS | 36.34x | 153.25x | 160.26x | -87.50x | 23.78x |
| Forward P/EPrice ÷ next-FY EPS est. | 3.27x | 78.42x | 118.01x | 53.52x | 23.40x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 1.02x |
| EV / EBITDAEnterprise value multiple | 89.92x | 66.40x | 24.31x | 66.86x | 16.72x |
| Price / SalesMarket cap ÷ Revenue | 4.48x | 13.99x | 7.05x | 0.76x | 11.47x |
| Price / BookPrice ÷ Book value/share | 2.07x | 3.35x | 3.18x | 6.36x | 2.63x |
| Price / FCFMarket cap ÷ FCF | 49.75x | 52.41x | 31.25x | 26.18x | 15.64x |
Profitability & Efficiency
OHI leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
OHI delivers a 11.9% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $1 for COMP. BEKE carries lower financial leverage with a 0.32x debt-to-equity ratio, signaling a more conservative balance sheet compared to VTR's 1.05x. On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs COMP's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +5.0% | +3.5% | +2.1% | +1.1% | +11.9% |
| ROA (TTM)Return on assets | +2.7% | +2.3% | +1.0% | +0.4% | +6.1% |
| ROICReturn on invested capital | +3.7% | +0.5% | +2.5% | -2.5% | +6.0% |
| ROCEReturn on capital employed | +4.7% | +0.6% | +3.2% | -2.9% | +7.9% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 | 6 | 4 | 6 |
| Debt / EquityFinancial leverage | 0.32x | 0.49x | 1.05x | 0.58x | 0.78x |
| Net DebtTotal debt minus cash | $11.2B | $16.3B | $12.5B | $255M | $4.2B |
| Cash & Equiv.Liquid assets | $11.4B | $5.0B | $741M | $199M | $27M |
| Total DebtShort + long-term debt | $22.7B | $21.4B | $13.2B | $454M | $4.3B |
| Interest CoverageEBIT ÷ Interest expense | 131.87x | 0.26x | 1.40x | -0.12x | 3.83x |
Total Returns (Dividends Reinvested)
WELL leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $30,234 today (with dividends reinvested), compared to $3,837 for BEKE. Over the past 12 months, WELL leads with a +42.7% total return vs BEKE's -4.8%. The 3-year compound annual growth rate (CAGR) favors COMP at 49.1% vs BEKE's 7.0% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +16.1% | +14.3% | +12.6% | -16.7% | +6.6% |
| 1-Year ReturnPast 12 months | -4.8% | +42.7% | +33.9% | +14.4% | +36.9% |
| 3-Year ReturnCumulative with dividends | +22.5% | +189.5% | +94.2% | +231.4% | +86.2% |
| 5-Year ReturnCumulative with dividends | -61.6% | +202.3% | +74.8% | -48.3% | +63.1% |
| 10-Year ReturnCumulative with dividends | -47.8% | +223.1% | +65.0% | -56.6% | +110.0% |
| CAGR (3Y)Annualised 3-year return | +7.0% | +42.5% | +24.8% | +49.1% | +23.0% |
Risk & Volatility
Evenly matched — VTR and OHI each lead in 1 of 2 comparable metrics.
Risk & Volatility
OHI is the less volatile stock with a -0.13 beta — it tends to amplify market swings less than COMP's 1.79 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VTR currently trades 97.8% from its 52-week high vs COMP's 62.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.83x | 0.13x | 0.01x | 1.79x | -0.13x |
| 52-Week HighHighest price in past year | $20.98 | $219.59 | $88.50 | $13.96 | $49.14 |
| 52-Week LowLowest price in past year | $14.40 | $142.65 | $61.76 | $5.66 | $35.09 |
| % of 52W HighCurrent price vs 52-week peak | +87.8% | +97.0% | +97.8% | +62.7% | +93.9% |
| RSI (14)Momentum oscillator 0–100 | 75.4 | 60.2 | 56.2 | 65.7 | 48.6 |
| Avg Volume (50D)Average daily shares traded | 4.0M | 2.6M | 3.4M | 14.5M | 1.9M |
Analyst Outlook
Evenly matched — BEKE and WELL and OHI each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BEKE as "Buy", WELL as "Buy", VTR as "Buy", COMP as "Buy", OHI as "Hold". Consensus price targets imply 63.3% upside for COMP (target: $14) vs 4.9% for VTR (target: $91). For income investors, OHI offers the higher dividend yield at 5.44% vs WELL's 1.30%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $22.13 | $226.50 | $90.80 | $14.29 | $49.14 |
| # AnalystsCovering analysts | 12 | 34 | 32 | 10 | 28 |
| Dividend YieldAnnual dividend ÷ price | +1.9% | +1.3% | +2.1% | — | +5.4% |
| Dividend StreakConsecutive years of raises | 2 | 2 | 1 | — | 0 |
| Dividend / ShareAnnual DPS | $2.40 | $2.76 | $1.86 | — | $2.51 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.2% | 0.0% | 0.0% | 0.0% | 0.0% |
OHI leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). WELL leads in 1 (Total Returns). 3 tied.
BEKE vs WELL vs VTR vs COMP vs OHI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BEKE or WELL or VTR or COMP or OHI a better buy right now?
For growth investors, Welltower Inc.
(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus 14. 0% for Omega Healthcare Investors, Inc. (OHI). Omega Healthcare Investors, Inc. (OHI) offers the better valuation at 23. 8x trailing P/E (23. 4x forward), making it the more compelling value choice. Analysts rate KE Holdings Inc. (BEKE) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BEKE or WELL or VTR or COMP or OHI?
On trailing P/E, Omega Healthcare Investors, Inc.
(OHI) is the cheapest at 23. 8x versus Ventas, Inc. at 160. 3x. On forward P/E, KE Holdings Inc. is actually cheaper at 3. 3x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — BEKE or WELL or VTR or COMP or OHI?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +202. 3%, compared to -61. 6% for KE Holdings Inc. (BEKE). Over 10 years, the gap is even starker: WELL returned +223. 1% versus COMP's -56. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BEKE or WELL or VTR or COMP or OHI?
By beta (market sensitivity over 5 years), Omega Healthcare Investors, Inc.
(OHI) is the lower-risk stock at -0. 13β versus Compass, Inc. 's 1. 79β — meaning COMP is approximately -1498% more volatile than OHI relative to the S&P 500. On balance sheet safety, KE Holdings Inc. (BEKE) carries a lower debt/equity ratio of 32% versus 105% for Ventas, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — BEKE or WELL or VTR or COMP or OHI?
By revenue growth (latest reported year), Welltower Inc.
(WELL) is pulling ahead at 35. 8% versus 14. 0% for Omega Healthcare Investors, Inc. (OHI). On earnings-per-share growth, the picture is similar: Ventas, Inc. grew EPS 184. 2% year-over-year, compared to -29. 4% for KE Holdings Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BEKE or WELL or VTR or COMP or OHI?
Omega Healthcare Investors, Inc.
(OHI) is the more profitable company, earning 49. 3% net margin versus -0. 8% for Compass, Inc. — meaning it keeps 49. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OHI leads at 62. 6% versus -0. 4% for COMP. At the gross margin level — before operating expenses — OHI leads at 44. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BEKE or WELL or VTR or COMP or OHI more undervalued right now?
On forward earnings alone, KE Holdings Inc.
(BEKE) trades at 3. 3x forward P/E versus 118. 0x for Ventas, Inc. — 114. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for COMP: 63. 3% to $14. 29.
08Which pays a better dividend — BEKE or WELL or VTR or COMP or OHI?
In this comparison, OHI (5.
4% yield), VTR (2. 1% yield), BEKE (1. 9% yield), WELL (1. 3% yield) pay a dividend. COMP does not pay a meaningful dividend and should not be held primarily for income.
09Is BEKE or WELL or VTR or COMP or OHI better for a retirement portfolio?
For long-horizon retirement investors, Omega Healthcare Investors, Inc.
(OHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 13), 5. 4% yield, +110. 0% 10Y return). Compass, Inc. (COMP) carries a higher beta of 1. 79 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (OHI: +110. 0%, COMP: -56. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BEKE and WELL and VTR and COMP and OHI?
These companies operate in different sectors (BEKE (Real Estate) and WELL (Real Estate) and VTR (Real Estate) and COMP (Technology) and OHI (Real Estate)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: BEKE is a mid-cap high-growth stock; WELL is a mid-cap high-growth stock; VTR is a mid-cap high-growth stock; COMP is a small-cap high-growth stock; OHI is a mid-cap income-oriented stock. BEKE, WELL, VTR, OHI pay a dividend while COMP does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.